Proteomics in Cancer Research - Softcover

 
9780471444756: Proteomics in Cancer Research

Inhaltsangabe

The book provides a broad view of proteomics in both basic and clinical cancer research, offering practical tools through discussion of methodology and procedures, as well as presentation of step-by-step protocols. It emphasizes the application of emerging technology to a broad range of research and therapeutic problems in cancer. It covers basic principles along with a detailed presentation of new and emerging applications.

Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.

Über die Autorin bzw. den Autor

Dr. Daniel C. Liebler is Professor, Department of Pharmacology and Toxicology, and Director, Southwest Environmental Health Sciences Center at the University of Arizona College of Pharmacy. He is also Director of the Toxicology Training Program and a member of the Arizona Cancer Center, as well as the author of Introduction to Proteomics (2001).

Von der hinteren Coverseite

Proteomics in Cancer Research

Edited by Daniel C. Liebler

Proteomics in Cancer Research covers both the basic principles of proteomics along with detailed presentations of new and emerging technology that represent promising breakthroughs in cancer prevention and treatment. The topics covered include:

  • Basic concepts, including setting up a proteomics laboratory, mass spectrometry, protein separations, protein array technologies, and informatics tools
  • Application of emerging technologies, to proteomic analysis of cancer cells and tissues, including discussion of critical issues such as characteristics of cancer cell proteomes and protein-protein interactions
  • Application of proteomics approaches in clinical cancer research and a forecast of future research and applications

In most cases, applications of methods in basic and translational cancer research that are discussed in the text represent the first uses of these proteomics approaches to study any disease.

Critical issues that readers in cancer research need to understand are covered in detail, including:

  • Advantages and limitations of different technologies
  • New approaches to the molecular classification of tumors
  • Discovery of new biomarkers and imaging targets and development of new proteomic platforms for profiling and screening

The unique proteomic features that characterize cancers offer new opportunities for disease prevention and treatment. Despite intense interest, however, proteomics is just beginning to become a part of the cancer research mainstream, as relatively few cancer researchers have training in proteomics methods and approaches. This book, therefore, is both a timely and an essential guide that will help readers understand key concepts of proteomics and use its methods to search for ways to both cure and prevent cancer.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Weitere beliebte Ausgaben desselben Titels

9780471444763: Proteomics In Cancer Research

Vorgestellte Ausgabe

ISBN 10:  0471444766 ISBN 13:  9780471444763
Verlag: John Wiley & Sons Inc, 2005
Hardcover